Skip to main content
CAISector not reported

Caris Life Sciences, Inc. (CAI) Insider Trading

In the last 90 days, 3 Caris Life Sciences, Inc. (CAI) insiders reported no open-market purchases and 3 sales totaling $27,204,795. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 22, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 22, 2026John Russel DentonSee RemarksSale7,500$31.82$238,626
Sep 17, 2026Brian J BrilleSee RemarksSale400,000$30.33$12,132,080
Sep 4, 2026David Baxley SpetzlerPresidentSale597,212$24.84$14,834,089
May 15, 2026Jon HalbertCorporate insiderOpen Market Purchase68,000$14.56$990,080
May 11, 2026Jeff L VacircaCorporate insiderOpen Market Purchase31,050$16.15$501,426

Common questions

CAI insider trading FAQ

Are CAI insiders buying or selling?
Over the last 90 days, CAI insiders were net sellers, reporting $0.00 of open-market purchases and $27,204,795 of sales.
When was the last CAI insider purchase?
No open-market insider purchase of Caris Life Sciences, Inc. stock was reported in the last 90 days.
Where does CAI insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Caris Life Sciences, Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.